STEPS-EA trial: an ERNICA multi-center controlled trial

24 April 2021

The STEPS-EA trial is an ERNICA multi-centre randomised controlled trial looking at intralesional steroid injections to prevent refractory strictures in patients with esophageal atresia. The trial involves 1:1 randomization to injection with 10 mg/ml TAC (Kenacort-A 10) prior to balloon dilatation and balloon dilatation without any injection.

Click here to access the latest STEPS-EA updates, via their newsletter (March 2021 issue)

If you have any questions regarding the STEPS-EA trial as a parent, patient or medical professional, please contact
The team are more than happy to help you, or include you.

The STEPSEA trial: intralesional STEroid injections to Prevent refractory Strictures in patients with Esophageal Atresia.

For more information about the STEPS-EA trial, you can watch the explainer video on ERNICA YouTube channel.



Leave a Reply

Your email address will not be published.